Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Absci (ABSI) Change in Acquisitions & Divestments (2022 - 2026)

Absci (ABSI) posted Change in Acquisitions & Divestments of $26.0 million for Q1 2026, up 503.25% sequentially from $4.3 million in Q4 2025, and up 4.0% YoY from $25.0 million in Q1 2025.

Analysis

Absci (ABSI) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends

Absci has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $26.0 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 4.0% year-over-year to $26.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.5 million (down 52.52% YoY) and the FY2025 annual result came in at $69.5 million, down 51.74% from the prior year.
  • Change in Acquisitions & Divestments advanced to $26.0 million in Q1 2026 per ABSI's latest filing, from $4.3 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $93.9 million in Q2 2023 and troughed at $4.3 million in Q4 2025.
  • A 5-year average of $33.9 million and a median of $30.8 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments surged 780.0% in 2023, then sank 90.42% in 2025.
  • Over 5 years, Change in Acquisitions & Divestments stood at $5.0 million in 2022, then jumped by 780.0% to $44.0 million in 2023, then climbed by 2.27% to $45.0 million in 2024, then tumbled by 90.42% to $4.3 million in 2025, then jumped by 503.25% to $26.0 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $26.0 million, $4.3 million, and $14.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Absci 1.39 Bn 1.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.99 Mn
Mar 31, 2026 26.00 Mn
Dec 31, 2025 4.31 Mn
Sep 30, 2025 14.19 Mn
Jun 30, 2025 26.00 Mn
Mar 31, 2025 25.00 Mn
Dec 31, 2024 45.00 Mn
Sep 30, 2024 43.00 Mn
Jun 30, 2024 35.50 Mn
Mar 31, 2024 20.50 Mn
Dec 31, 2023 44.00 Mn
Sep 30, 2023 50.00 Mn
Jun 30, 2023 93.90 Mn
Mar 31, 2023 42.00 Mn
Dec 31, 2022 5.00 Mn